OpenVSafe by OpenVAERS
Search V-safe

ZZV-25363-91825

2 vaccinations 6 coded responses 13 check-ins 6 free-text entries 4 call cases
Sex
Male
Age at first dose
61-65
ZIP prefix
100 / NY
Registered
2021-02-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-22
    Registered in v-safe
  3. 2021-02-25
    Survey response — day 7, dose 1
    MedDRA: Seizure — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work
    Free text: Seizure
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-06
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  5. 2021-03-10
    Dose 2 — Pfizer-BioNTech
  6. 2021-03-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to work
    Adult check-in
  7. 2021-03-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Seizure — Feeling: Fair · Fatigue or tiredness
    Free text: Seizure
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  9. 2021-03-17
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  10. 2021-03-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-04-02
    Survey response — day 21, dose 2
    MedDRA: Blood test, Cataract, Echocardiogram, Hypercalcaemia, Hyperparathyroidism, Office visit, Scan myocardial perfusion, Ultrasound scan — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Hypercalcimium, hyper parathyroidism , developing cataracts · Healthcare visit (other): Multiple blood tests, multiple eye studies, ultrasound study, echocardiogram, scheduled for nuclear medicine study, MRI
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-02
    Report sent to call center — day 21, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-04-10
    Survey response — day 28, dose 2
    MedDRA: Echocardiogram, Hypercalcaemia, Hyperparathyroidism, Laboratory test, Magnetic resonance imaging, Ultrasound scan, Unevaluable event — Feeling: Poor · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Hypercalcimum secondary to hyper parathyroidism · Healthcare visit (other): MRI, echo cardio gram, ultrasound of kidneys, labs
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-10
    Report sent to call center — day 28, dose 2
    Be unable to work · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-04-14
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  16. 2021-04-21
    Survey response — day 42, dose 2
    MedDRA: Blood calcium increased, Blood parathyroid hormone increased, Hypercalcaemia, Hyperparathyroidism, Office visit, Parathyroid gland enlargement — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Hyper parathyroidism,hyper calcium, high PTH. · Healthcare visit (other): Visit to head and neck surgeon; more labs
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-21
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-06-10
  19. 2021-06-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-09-08
    Survey response — 6 months, dose 2
    MedDRA: Decreased appetite, Dyspnoea, Headache — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Shortness of breath, headache, loss of appetite
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-09-08
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  22. 2021-09-09

Vaccinations

DoseDateManufacturerCo-administered
12021-02-18Pfizer-BioNTech
22021-03-10Pfizer-BioNTech

Call center

4 call center cases

4 unsuccessful

See the call center timeline

Free text

Release 4 — day 7, dose 1

2021-02-25

Systemic reaction (other): Seizure

Release 5 — days 1–6 daily, dose 2

2021-03-15

Systemic reaction (other): Seizure

Release 6 — day 21, dose 2

2021-04-02

Symptoms: Hypercalcimium, hyper parathyroidism , developing cataracts
Healthcare visit (other): Multiple blood tests, multiple eye studies, ultrasound study, echocardiogram, scheduled for nuclear medicine study, MRI

Release 7 — day 28, dose 2

2021-04-10

Symptoms: Hypercalcimum secondary to hyper parathyroidism
Healthcare visit (other): MRI, echo cardio gram, ultrasound of kidneys, labs

Release 7 — day 42, dose 2

2021-04-21

Symptoms: Hyper parathyroidism,hyper calcium, high PTH.
Healthcare visit (other): Visit to head and neck surgeon; more labs

Release 9 — 6 months, dose 2

2021-09-08

Symptoms: Shortness of breath, headache, loss of appetite

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOBlood test ○ ✓ ○
HCVOEchocardiogram ✓ ✓ ○
HCVOLaboratory test ✓ ✓ ○
HCVOMagnetic resonance imaging ✓ ✓ ○
HCVOOffice visit ✓ ✓ ✓
HCVOScan myocardial perfusion ○ ✓ ○
HCVOUltrasound scan ✓ ✓ ○
HCVOUnevaluable event ✓ · ✓
SDBlood calcium increased ○ ✓ ○
SDBlood parathyroid hormone increased ✓ · ✓
SDCataract ✓ ✓ ✓
SDDecreased appetite · · ✓
SDDyspnoea · · ✓
SDHeadache · · ✓
SDHypercalcaemia ✓ ✓ ✓
SDHyperparathyroidism ✓ ✓ ✓
SDParathyroid gland enlargement ○ ✓ ○
SROSeizure ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release